Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration

• Published in: European journal of radiology Vol. 80; no. 2; pp. 378 - 386
• Main Authors: Chou, Shinn-Huey, Wang, Zhen J, Kuo, Jonathan, Cabarrus, Miguel, Fu, Yanjun, Aslam, Rizwan, Yee, Judy, Zimmet, Jeffrey M, Shunk, Kendrick, Elicker, Brett, Yeh, Benjamin M
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier Ireland Ltd 01.11.2011; Elsevier
• Subjects: Adult; Age Factors; Aged; Aged, 80 and over; Biological and medical sciences; Contrast; Contrast Media - administration & dosage; Contrast media. Radiopharmaceuticals; Contrast-induced nephropathy; Creatinine - blood; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Intra-arterial; Intravenous; Kidney - diagnostic imaging; Kidney Diseases - chemically induced; Kidney Diseases - diagnostic imaging; Male; Medical sciences; Middle Aged; Persistent enhancement; Pharmacology. Drug treatments; Radiology; Regression Analysis; Renal; Retrospective Studies; Tomography, X-Ray Computed; Triiodobenzoic Acids - administration & dosage; CT; Intravenous; Renal; Persistent enhancement; Contrast; Contrast-induced nephropathy; Intra-arterial; Kidney disease; Urinary system disease; Non ionic contrast media; Intravenous administration; Radiodiagnosis; Renal artery; Toxicity; Iodine Organic compounds; Kidney; Nephropathy; Urinary system; Medical imagery; Computerized axial tomography; Iodixanol; Comparative study; Contrast media

Abstract Purpose To examine the clinical significance of persistent renal enhancement after iodixanol administration. Methods We retrospectively studied 166 consecutive patients who underwent non-enhanced abdominopelvic CT within 7 days after receiving intra-arterial ( n = 99) or intravenous ( n = 6...